Chromosome fragility and predisposition to childhood malignancies. 1998

A Kolialexi, and A Mavrou, and C Tsenghi, and G T Tsangaris, and E Dafermou, and F Tzortzatou, and S Polychronopoulou, and S Haidas, and C Metaxotou
1st Department of Pediatrics, Athens University, Aghia Sophia Children's Hospital, Greece.

In order to clarify the possible connection between autosomal folate sensitive Fragile Sites (FS) and genetic susceptibility to haemopoetic disease in children we investigated the frequency and distribution of FS in the Peripheral Blood Lymphocytes (PBL) of 56 children with newly diagnosed and untreated haematologic malignancies and their parents. The incidence was compared with that of 146 normal controls (children and adults). In all patients the Bone Marrow (BM) karyotype was also determined. Heritable FS were detected in 49 patients (87.5%). 20 children had more than one FS and in all cases it was inherited from one of their parents, although there was a significant excess of transmitting mothers. 19 different FS were identified: 14 common, 4 rare and one, 22q11, which has not been previously reported, but it is considered as important as it coincides with the cancer breakpoint resulting in the formation of the Philadelphia (Ph) chromosome. The frequency of FS in the PBL of the patients was significantly higher than in the controls and this increase was independent of any abnormality detected in the malignant cells of the BM. However, patients with an abnormal BM karyotype displayed increased frequency of FS induction as compared to patients with a normal karyotype. In three cases the heritable FS was found to be at or near the breakpoints of the chromosomal rearrangements detected in the malignant cells. The findings are discussed with regard to cancer specific breakpoints, oncogene loci and sites where viral DNA can be inserted to the genome. The results of this study suggest that autosomal folate sensitive FS may increase the risk for haematologic malignancies through a complex mechanism which remains to be clarified.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D007621 Karyotyping Mapping of the KARYOTYPE of a cell. Karyotype Analysis Methods,Analysis Method, Karyotype,Analysis Methods, Karyotype,Karyotype Analysis Method,Karyotypings,Method, Karyotype Analysis,Methods, Karyotype Analysis
D007938 Leukemia A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006) Leucocythaemia,Leucocythemia,Leucocythaemias,Leucocythemias,Leukemias
D008214 Lymphocytes White blood cells formed in the body's lymphoid tissue. The nucleus is round or ovoid with coarse, irregularly clumped chromatin while the cytoplasm is typically pale blue with azurophilic (if any) granules. Most lymphocytes can be classified as either T or B (with subpopulations of each), or NATURAL KILLER CELLS. Lymphoid Cells,Cell, Lymphoid,Cells, Lymphoid,Lymphocyte,Lymphoid Cell
D008223 Lymphoma A general term for various neoplastic diseases of the lymphoid tissue. Germinoblastoma,Lymphoma, Malignant,Reticulolymphosarcoma,Sarcoma, Germinoblastic,Germinoblastic Sarcoma,Germinoblastic Sarcomas,Germinoblastomas,Lymphomas,Lymphomas, Malignant,Malignant Lymphoma,Malignant Lymphomas,Reticulolymphosarcomas,Sarcomas, Germinoblastic
D008297 Male Males
D009190 Myelodysplastic Syndromes Clonal hematopoietic stem cell disorders characterized by dysplasia in one or more hematopoietic cell lineages. They predominantly affect patients over 60, are considered preleukemic conditions, and have high probability of transformation into ACUTE MYELOID LEUKEMIA. Dysmyelopoietic Syndromes,Hematopoetic Myelodysplasia,Dysmyelopoietic Syndrome,Hematopoetic Myelodysplasias,Myelodysplasia, Hematopoetic,Myelodysplasias, Hematopoetic,Myelodysplastic Syndrome,Syndrome, Dysmyelopoietic,Syndrome, Myelodysplastic,Syndromes, Dysmyelopoietic,Syndromes, Myelodysplastic
D012016 Reference Values The range or frequency distribution of a measurement in a population (of organisms, organs or things) that has not been selected for the presence of disease or abnormality. Normal Range,Normal Values,Reference Ranges,Normal Ranges,Normal Value,Range, Normal,Range, Reference,Ranges, Normal,Ranges, Reference,Reference Range,Reference Value,Value, Normal,Value, Reference,Values, Normal,Values, Reference
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children

Related Publications

A Kolialexi, and A Mavrou, and C Tsenghi, and G T Tsangaris, and E Dafermou, and F Tzortzatou, and S Polychronopoulou, and S Haidas, and C Metaxotou
January 2023, Mediterranean journal of hematology and infectious diseases,
A Kolialexi, and A Mavrou, and C Tsenghi, and G T Tsangaris, and E Dafermou, and F Tzortzatou, and S Polychronopoulou, and S Haidas, and C Metaxotou
June 2022, Blood cancer journal,
A Kolialexi, and A Mavrou, and C Tsenghi, and G T Tsangaris, and E Dafermou, and F Tzortzatou, and S Polychronopoulou, and S Haidas, and C Metaxotou
September 2019, Blood advances,
A Kolialexi, and A Mavrou, and C Tsenghi, and G T Tsangaris, and E Dafermou, and F Tzortzatou, and S Polychronopoulou, and S Haidas, and C Metaxotou
October 2021, Human molecular genetics,
A Kolialexi, and A Mavrou, and C Tsenghi, and G T Tsangaris, and E Dafermou, and F Tzortzatou, and S Polychronopoulou, and S Haidas, and C Metaxotou
June 2016, [Rinsho ketsueki] The Japanese journal of clinical hematology,
A Kolialexi, and A Mavrou, and C Tsenghi, and G T Tsangaris, and E Dafermou, and F Tzortzatou, and S Polychronopoulou, and S Haidas, and C Metaxotou
June 2008, Hereditary cancer in clinical practice,
A Kolialexi, and A Mavrou, and C Tsenghi, and G T Tsangaris, and E Dafermou, and F Tzortzatou, and S Polychronopoulou, and S Haidas, and C Metaxotou
July 2017, Blood,
A Kolialexi, and A Mavrou, and C Tsenghi, and G T Tsangaris, and E Dafermou, and F Tzortzatou, and S Polychronopoulou, and S Haidas, and C Metaxotou
October 2016, Seminars in oncology,
A Kolialexi, and A Mavrou, and C Tsenghi, and G T Tsangaris, and E Dafermou, and F Tzortzatou, and S Polychronopoulou, and S Haidas, and C Metaxotou
August 2017, International journal of hematology,
A Kolialexi, and A Mavrou, and C Tsenghi, and G T Tsangaris, and E Dafermou, and F Tzortzatou, and S Polychronopoulou, and S Haidas, and C Metaxotou
October 1982, Archives francaises de pediatrie,
Copied contents to your clipboard!